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Abstract: Mitochondrial unfolded protein response is a form of retrograde signaling  
that contributes to ensuring the maintenance of quality control of mitochondria, allowing 
functional integrity of the mitochondrial proteome. When misfolded proteins or unassembled 
complexes accumulate beyond the folding capacity, it leads to alteration of proteostasis, 
damages, and organelle/cell dysfunction. Extensively studied for the ER, it was recently 
reported that this kind of signaling for mitochondrion would also be able to communicate 
with the nucleus in response to impaired proteostasis. The mitochondrial unfolded protein 
response (UPRmt) is activated in response to different types and levels of stress, especially 
in conditions where unfolded or misfolded mitochondrial proteins accumulate and aggregate. 
A specific UPRmt could thus be initiated to boost folding and degradation capacity in response 
to unfolded and aggregated protein accumulation. Although first described in mammals,  
the UPRmt was mainly studied in Caenorhabditis elegans, and accumulating evidence 
suggests that mechanisms triggered in response to a UPRmt might be different in C. elegans 
and mammals. In this review, we discuss and integrate recent data from the literature to address 
whether the UPRmt is relevant to mitochondrial homeostasis in mammals and to analyze the 
putative role of integrated stress response (ISR) activation in response to the inhibition of 
mtDNA expression and/or accumulation of mitochondrial mis/unfolded proteins. 
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1. Introduction 
Mitochondrial, multifunctional, and dynamic organelles (resulting from fusion and fission events of 
mitochondria fragments, according to cell type and conditions) are linked to pathologies far beyond the 
sensu stricto “mitochondrial diseases” because they regulate metabolism via the Krebs cycle and oxidative 
phosphorylation (OXPHOS). Linked to their bioenergetics, mitochondria that contain more than 1000 
different proteins/peptides, synthesized from both mitochondrial and nuclear genomes in a coordinated 
manner [1,2] also participate in synthesis (steroids, amino acids, nucleotides), the biogenesis of  
iron-sulfur centers, calcium homeostasis and redox status [3], control epigenetics marks in the nuclear 
genome, and constitute an integration platform for signaling and cell death/survival signals, connecting 
the organelle to apoptosis and autophagy [4–7]. The continued organelle maintenance can be seen as  
a balance between the biogenesis of the organelle and the mechanisms that provide quality control 
(involved in the remodeling and mitophagy) that guarantees cell homeostasis and function [8,9]. This 
function is maintained by the participation of several chaperones, antioxidant enzymes (SOD2, PRDX3, 
PRDX5, GPX1: human nomenclature according to Uniprot), and quality control proteases that promote 
protein folding and stability on the mitochondria while performing the degradation of un- or mis-folded 
proteins that accumulate [10]. Essential for this control is the molecular communication between  
the mitochondria and nucleus, in which ATP, calcium, and reactive oxygen species have been described 
to play major roles [1,11–14]. Indeed, upon organelle dysfunction, which can be caused by many events, 
such as mtDNA depletion, mutations, deletions, oxidative stress, aggregation of misfolded proteins,  
or dramatic changes in morphology and dynamics, a mitochondrial-to-nucleus communication, known 
as “retrograde signaling,” triggers an orchestrated expression of nuclear genes in an attempt to 
relieve/resolve the stress and/or to compensate the defect [15]. The importance of these stress response 
pathways can be highlighted by the various pathophysiological developments associated with their 
impairment [15]. The aim of the current review is to highlight recent developments in the role of 
mitochondrial unfolded protein response (UPRmt) in the field of mitochondrial dysfunction and putative 
connection with other retrograde signaling pathways, with a particular focus on differences between 
mechanisms retrieved in mammals and other organisms. 
1.1. Mitochondrial Retrograde Responses 
Several signaling pathways have been described in the mitochondria-to-nucleus communication 
observed in response to organelle stress and dysfunction. This mitochondrial stress response can be 
perceived as an attempt to compensate for the metabolic defect by stimulating several biological 
processes including mitochondria biogenesis. The transcriptional regulation of mitochondrial biogenesis 
is mediated by a set of transcription factors such as NRF1 and NRF2/GA-binding protein subunit ȕ-1 
(nuclear respiratory factors 1 and 2), cyclicAMP-responsive element binding protein1 (CREB1), steroid 
hormone receptor ERR1 (ERRĮ), and PPARG (PPARȖ). The activity of these transcription factors is 
coordinated by members of the PGC-1 co-activator family [16]. The retrograde communication often 
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relies on some of these transcriptional regulators to modulate gene expression to adapt mitochondria 
function in response to the original cue and promote recovery and function to resolve the stress.  
We now discuss the signaling pathways that regulate the expression, localization, and activity of these 
transcription factors. Notably, if the following pathways are usually associated with the regulation of 
mitochondrial protein abundance, lipid content might also be regulated and controlled by retrograde 
signaling. As with the absence of mtDNA in HeLa cells, mitochondrial DNA absence sensitive (MIDAS) 
factor increases mitochondrial mass by regulating the expression of enzymes involved in cardiolipin 
synthesis [17]. 
Retrograde communication in response to mitochondrial stress comes from seminal studies from 
Butow’s group in the budding yeast Saccharomyces cerevisiae depleted of mtDNA [18,19], which 
showed that electron transport chain (ETC) deficiency leads to the transcription of genes associated with 
glutamate metabolism (reviewed in [20]). In yeast, there are three retrograde response genes (RTG): 
Rtg1p and Rtg3p are transcription factors, forming a dimer that translocates from the cytosol to the 
nucleus to regulate gene expression, while Rtg2p would act/behave as a sensor of mitochondrial  
stress [21]. Although mammalian orthologs of these proteins have not been found, similar signaling 
pathways do exist in mammals, as detailed in the next section. 
1.1.1. Retrograde Signaling Involving Increased Cytosolic Calcium Concentration 
Pioneering works on retrograde signaling in mammalian cells have been described in mtDNA-depleted 
cells through the pharmacological inhibition of ETC complexes or disruption of the mitochondrial 
membrane potential and focused on calcium in mouse C2C12 myocytes and human pulmonary carcinoma 
A549 cells. Avadhani’s group showed that mitochondrial dysfunction associated with membrane 
depolarization leads to increased cytosolic calcium concentration and triggers nuclear factor of activated 
T-cells (NF-AT) and activating transcription factor 2 (ATF2) translocation to the nucleus in a calcineurin 
(Cn)- and Mitogen-activated protein kinase 8 (MAPK8)/JNK1-dependent manner, respectively [11,22]. 
The list of transcriptional regulators activated by calcium, either by a phosphorylation in a JNK1- 
or calcium/calmodulin-dependent protein kinase type IV (CaMKIV)-dependent manner, or by a 
dephosphorylation mediated by calcineurin in response to mitochondrial dysfunction has now expanded 
and includes the transcription factors CREB1, nuclear factor of ț light polypeptide gene enhancer in 
B-cells 1 (NF-țB), cellular tumor antigen p53 (p53), myocyte-specific enhancer factor 2A (MEF-2),  
and co-activators peroxisome proliferator-activated receptor Ȗ coactivator 1-Į (PGC-1Į) and heterogenous 
nuclear ribonucleoprotein A2 (hnRNPA2) [13,22–25]. Altogether, data about calcium-dependent 
mitochondrial retrograde response represent a good example of functional compensation after organelle 
stress. Overexpressed nuclear genes include proteins associated with calcium homeostasis, such as 
calsequestrin and calreticulin, OXPHOS subunits for stabilizing energy production, and chloride 
intracellular channel protein 4 (Clic 4), which contribute to mitochondrial membrane potential [26–28]. 
1.1.2. Retrograde Response Associated with ROS Production and Signaling 
Reactive oxygen species (ROS) are by-products of ETC complexes, and while they represent 
important physiological second messengers, their excessive production can lead to protein, lipid, and 
DNA damages and, ultimately, cell death. When antioxidant defenses are overwhelmed, a transcriptional 
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program regulated by the NRF2/GA-binding protein subunit ȕ-1 is initiated [29]. Indeed, excessive 
production of ROS triggers the stabilization and translocation of the factor to the nucleus, where the 
transcription of target genes containing an antioxidant-response element (ARE) in their promoter is 
increased, including NRF1, which regulates mitochondrial gene expression [29,30]. It has also been 
suggested that NRF1 might be directly regulated by redox signaling in phosphatidylinositol 3-kinase 
(PI3K) and RAC-Į serine/threonine-protein kinase/Akt-dependent manners to regulate mtDNA 
transcription and replication by increasing mitochondrial transcription factor A (TFAM) protein 
expression [31]. PGC-1Į is also activated by AMP-activated protein kinase (AMPK) in response to 
mitochondrial ROS to promote organelle biogenesis [32]. As for calcium, ROS have been the focus of 
numerous studies on retrograde communication, and additional transcription factors, such as NF-țB, 
p53, and AP-1, are activated by oxidants [33–35]. Surprisingly, while several studies have demonstrated 
enhanced biogenesis in response to mitochondrial stress [33,36–38], recent biological analysis of 
retrograde signaling by Chae and collaborators demonstrated the role of ROS in the down-regulation of 
OXPHOS enzymes [39]. These authors reported that, among the 72 transcription factors, for which 
activity was modified in response to mtDNA mutation, the abundance of RXRĮ Retinoic acid receptor 
RXR Į) decreased after ROS-dependent JNK1 activation. As a direct consequence, the interaction 
between RXRĮ and PGC-1Į was reduced, which attenuated the expression of gene encoding of OXPHOS 
enzymes as well as mitochondrial ribosomal proteins—two phenomena that further exacerbate 
mitochondrial dysfunction [39]. 
1.1.3. Energy Deprivation and Retrograde Response 
The most obvious retrograde signaling might be the stress response associated with energy deprivation. 
AMPK is a sentinel activated in response to an increase in the AMP/ATP ratio, which triggers allosteric 
activation and the serine/threonine-protein kinase STK11 (LKB1)-dependent Thr172 phosphorylation 
of AMPK. Once activated, AMPK increases ATP production by inducing mitochondrial biogenesis, thus 
stimulating fatty acid ȕ-oxidation and glycolysis, and shuts down energy consuming processes such as 
cell growth and lipid and protein synthesis [40–43]. AMPK regulates PGC-1Į activity and abundance 
as well as its binding activity to transcription factors, such as NRF1, at the promoter of nuclear gene 
encoding mitochondrial proteins [36,42]. Moreover, AMPK is also well-known for regulating the 
serine/threonine-protein kinase mammalian target of rapamycin (mTOR) through control of tuberous 
sclerosis 2 (Tuberin) activity [44]. In mammals, two complexes have been described: mTORC1 and 
mTORC2. While mTORC1 regulates processes, such as transcription, translation, autophagy,  
and metabolism, mTORC2 is mainly associated with cell survival, proliferation, and metabolism.  
The activities of mTOR complexes are negatively regulated by Hamartin/Tuberin (tuberous sclerosis 1/2) 
via phosphorylation. In response to mitochondrial stress and energy deprivation, AMPK decreases 
mTOR activity and downstream processes, such as protein synthesis, by a mechanism involving 
either direct phosphorylation of the raptor or the activating phosphorylation of Tuberin [41,43,44]. 
Finally, the NAD+/NADH ratio and acetyl-coenzyme A (acetyl-CoA) are important mitochondrial 
coenzymes and metabolites, respectively, which are associated with retrograde response [45]. However, 
the reduction of NAD+ into NADH during the Krebs cycle and its oxidation by the NADH dehydrogenase 
complex represent the basis of mitochondrial respiration. Because NAD+ is also a substrate used by 
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enzymes, such as poly[ADP-ribose] polymerase-1 (PARP-1) and Sirtuins, the NAD+/NADH ratio, 
which not only results from the redox status of the molecule, but also a balance between its synthesis 
and its degradation, might modulate gene expression [46]. Conversely, acetyl-CoA, resulting from 
pyruvate metabolism and fatty acid ȕ-oxidation, is a substrate for lysine acetylation by acetyltransferases 
that controls the acetylation status of the transcription factors of the forkhead box protein O family 
members [47], histone acetylation, chromatin remodeling, and thus gene expression [48,49]. Yet, even 
if both NAD+/NADH and acetyl-CoA are associated with the activity of post-translational modifying 
enzymes, and thus regulation of signaling pathways or gene expression, their direct involvement in 
retrograde signaling has not been extensively characterized to date. 
1.1.4. Beyond Regulation by Transcription Factors 
Beyond this level of retrograde communication, which regulates nuclear gene expression by the 
activation of transcription factors, it has been shown that the mtDNA copy number can also lead to 
epigenetic modifications. It is known that ATP, acetyl-CoA concentration, NAD+/NADH ratio, and 
SAM (s-adenosylmethionine) are cofactors and metabolites whose concentrations can be modulated by 
mitochondria. Several of them, such as acetyl-CoA and SAM, are important acetyl- or methyl-group 
donors for DNA, RNA, and protein modifications that could also control gene expression and contribute 
to adaptation to mitochondria dysfunction [50]. These molecules can thus be seen as messengers for 
retrograde signaling responses [50]. 
Indeed, it has been demonstrated that mitochondrial depletion leads to increased promoter 
methylation of nuclear genes, which can be reverted, at least partly, by mtDNA repletion [7]. In addition, 
in conditions of mitochondrial stress, mitochondria-to-nucleus signaling is also know to confer a  
long-term adaptive response to the cell, which can protect it from future insults related or not to the 
initial stress. This concept, called mitochondrial hormesis or mitohormesis, provides a long-term 
increase in cytoprotective function after mild and transient mitochondrial stress such as ROS production. 
Mitohormesis has been particularly highlighted in the context of increased lifespan in various organisms 
such as yeast, worms, flies, and mice [51]. Moreover, it has been suggested that mitochondrial stress can 
generate a non-cell-autonomous response, meaning the activation of a stress response in a cell/tissue that 
is not affected by the initial triggered stress event. For instance, in response to OXPHOS deficiency, 
muscle fibers secrete the cytokine fibroblast growth factor 21 (FGF21) in the bloodstream, which  
results in chronic lipid recruitment and mobilization from adipose tissue and triggers ketogenesis in the  
liver [52,53]. It seems that skeletal muscle increases FGF21 expression in mitochondrial disorders to 
compensate for metabolic insufficiency by activating the mTOR Transcriptional repressor protein  
YY1-PGC-1Į pathway [54]. Durieux and co-workers have described another example in C. elegans,  
in which stressed mitochondria, via electron chain manipulations in key tissues, release soluble signals 
(the so-called mitokines), which trigger expression of cytoprotective genes in distal tissues and have a 
beneficial effect on longevity of the worm [55]. Mitokines have also been unveiled in the context of  
a recent retrograde response, which we discuss in the next sections of this review: the mitochondrial 
unfolded protein response (UPRmt). Following the example of the endoplasmic reticulum unfolded 
protein response (UPRer), when damaged and/or unfolded proteins accumulate within mitochondria,  
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this stress response coordinates expression of chaperones and proteases in a positive feedback loop and 
results in a first attempt to resolve the stress and bring cytoprotection [56]. 
1.2. The Mitochondrial Unfolded Protein Response (UPRmt) 
Protein homeostasis relies on the equilibrium between the number of unfolded proteins and the 
folding capacity of a compartment. The mitochondria possess their own arsenal of chaperones and 
proteases. When unfolded, misfolded, or unassembled proteins accumulate beyond folding capacity, this 
leads to damage and organelle/cell dysfunction. As seen previously, mitochondrion is able to communicate 
with the nucleus in response to organelle dysfunction and bioenergetic impairment. As with the 
endoplasmic reticulum, for which the different signaling pathways and branches of the unfolded protein 
response are well described [57], and affecting the regulation of autophagy and the biology of 
mitochondria [58,59], a specific UPRmt could also be initiated to boost folding and degradation capacity 
in response to unfolded and aggregated protein accumulations in mitochondria. Thus, mitochondrial protein 
homeostasis—or proteostasis—is preserved by retrograde communication to coordinate transcriptional 
activation of nuclear-encoded mitochondrial chaperones and proteases. Although its existence was 
initially reported in mammals almost 20 years ago [60], later studies related to the UPRmt mainly focused 
in Caenorhabditis elegans, with mechanisms mainly revealed in the model organism and linked to aging, 
healthy lifespan, and longevity [61–63]. The UPRmt is now considered as a mechanism that allows 
synchronization of nuclear and mitochondrial genomes [64]. 
1.2.1. The UPRmt in C. elegans 
Stress Models for the Study of UPRmt 
The worm C. elegans has been a useful model to identify stresses that activate a UPRmt and to decipher 
signaling from proteotoxic stress to expression of stress-responsive genes. Most of the time, the 
induction of the UPRmt can be easily assayed in worms that express green fluorescent protein (GFP) 
under the control of the promoter that drives the expression of gene encoding chaperones and orthologues 
of the mammalian mtHSP70 and heat shock 60 kDa protein 1 (HSPD1), respectively [61–63]. Ethidium 
bromide, an inhibitor of the mitochondrial DNA polymerase Ȗ (POLG) was the first UPRmt stressor 
described in C. elegans [65]. Because mitochondrial ETC complexes rely on a precise stoichiometry 
between nuclear- and mtDNA-encoded proteins, it is reasonable to think that the inhibition of 
mitochondrial transcription and replication by ethidium bromide, as transcriptions in mitochondria, 
clearly depend on mtDNA replication [66], which will lead to a protein imbalance and an increase in 
unassembled components. Similar mechanisms were later used to induce a UPRmt with other molecules. 
On the one hand, decreasing mtDNA-encoded proteins through interference with mitochondrial 
translation, either with inhibitors, such as doxycycline, or with siRNA, allowing the silencing of 
mitoribosomal proteins, triggers a UPRmt [46]. On the other hand, the stimulation of organelle 
biogenesis, by NAD+ supplementation or mTOR inhibition by rapamycin, has similar effects [67]. 
Additional stresses, which induce a UPRmt, following impaired assembly of mitochondrial complexes, 
defective protein folding, or processing, have also been described in a genome-wide RNAi screen [65]. 
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Signaling Pathway of the UPRmt 
Ten years of research using the UPRmt reporter in worms and large-scale experiments with siRNA 
were needed to shed light on a currently well-accepted model of retrograde signaling that followed 
mitochondrial proteotoxic stress in C. elegans. Briefly, accumulating unfolded proteins within 
mitochondria are degraded by the ATP-dependent Clp protease proteolytic subunit (ClpP) into small 
peptides, which are actively exported across the inner mitochondrial membrane (IMM) by HAF-1,  
a matrix peptide exporter belonging to the ATP-binding cassette (ABC) transporters [68,69]. Passive 
diffusion then brings peptides through the outer mitochondrial membrane (OMM) to the cytosol that 
triggers nuclear translocation of activating transcription factor associated with stress-1 (ATFS-1),  
a transcription factor that orchestrates expression of mitochondrial chaperones and proteases as well as 
other genes associated with ROS detoxification, mitochondrial protein import, and glycolysis [70]. 
Experiments in which the expression of ClpP and HAF-1 was silenced confirmed that both proteins were 
essential for the nuclear translocation of ATFS-1 and the activation of a UPRmt [68,69]. The mechanism 
that controls the cellular localization of ATFS-1 was recently discovered [70]. In addition to its nuclear 
localization sequence (NLS), the transcription factor also contains a mitochondrial targeting sequence 
(MTS). Under basal conditions, ATFS-1 is constitutively imported in mitochondria and degraded by the 
Lon protease [71]. However, upon mitochondrial proteotoxic stress conditions, mitochondrial import 
efficiency decreases, and a fraction of ATFS-1 proteins accumulates in the cytosol and translocates to 
the nucleus. Very recently, Haynes and colleagues showed that the ATFS-1 transcription factor not  
only induces chaperones, OXPHOS assembly factor, and glycolysis genes, but also directly regulates 
OXPHOS gene promoters by limiting the accumulation of OXPHOS transcripts. Altogether, ATFS-1 
coordinates the abundance of transcripts involved in OXPHOS expression and assembly factors to the 
protein-folding capacity of mitochondria [72]. The importance of the efficiency of the import machinery 
of mitochondrial proteins in the re-localization of ATFS-1 is supported by the fact that the disruption of 
mitochondrial import in response to the silencing of the mitochondrial import inner membrane 
translocase subunit Tim23 is sufficient to trigger ATFS-1 accumulation in the nucleus. It can also activate 
the GFP reporter construct driven by the promoter of HSPD1 encoding HSP60 [70], a mitochondrial 
matrix chaperonin crucial for the folding and assembly of newly imported mitochondrial proteins [73]. 
Interestingly, Rainbolt and colleagues obtained similar results and showed an increase in the 
expression of HSP60-GFP in response to the silencing of Tim17, a response that can be prevented in 
ATFS-1 but not HAF-1 mutant worms [74]. In addition, these authors noted that silencing of either 
Tim23 or Tim17 conferred increased resistance to paraquat-induced oxidative stress, although the 
protection was rather modest in mammalian cells. However, increased resistance to oxidative stress was 
not disrupted in the ATFS-1 mutant worm, thereby questioning the active participation of the UPRmt in 
this protection. Finally, while the reduced protein import was able to induce stress-responsive genes 
independently of mitochondrial matrix stress (HAF-1 mutant), in the context of a UPRmt, both the 
reduced mitochondrial protein import and the ATFS-1 nuclear translocation relied on HAF-1 and 
peptides efflux; however, the precise mechanism and tight regulation are still unclear [70]. 
In addition to ATFS-1, in C. elegans, the transcription factors DVE-1 and ubiquitin-like protein 5 
(UBL-5) appear to be involved in the transcriptional regulation of the UPRmt. During the onset of 
mitochondrial stress, both proteins redistribute into the nucleus and form a complex that binds the 
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promoter of gene encoding chaperones such as mtHSP70 and HSPD1. As for ATFS-1, ClpP is also 
required for DVE-1 nuclear translocation, but HAF-1 would be dispensable [68]. While these proteins 
might help in chromatin remodeling to facilitate ATFS-1 access to the promoters of the specific target 
genes of the UPRmt, future research on the importance of the contribution of DVE-1/UBL-5 complex to 
the UPRmt is still needed. In addition, it is also very likely that the activation of a UPRmt could be 
accompanied by signals that trigger and connect the activation of other cell signaling pathways. 
Crosstalk between the UPRmt and Other Stress Pathways in C. elegans 
The UPRmt relies on more than the over-expression of chaperones and proteases to maintain mitochondria 
proteostasis; several genes that are directly or indirectly controlled by ATFS-1 have been identified by 
comparing the relative abundance of transcripts between wild type and ATFS-1 mutant worms raised 
either under basal or UPRmt-inducing conditions. In these conditions, among 685 genes differentially 
expressed in response to the UPRmt, only 391 genes (encoding important components of ROS 
detoxification and antioxidant enzymes, glycolytic enzymes, and proteins of the mitochondrial protein 
import machinery) seemed to be dependent on ATFS-1, suggesting the activation of other pathways [70]. 
Other studies described the UPRmt as interconnected cell signaling with other stress-activated pathways 
such as the integrative stress response (ISR) [75] and the antioxidant response [67]. Baker and co-workers 
demonstrated that, during mitochondrial stress, eIF2Į is phosphorylated by GCN2 in a ROS-dependent 
manner, attenuating the protein synthesis within the cytosol. This is similar to what happens in the  
well-characterized UPRer [75]. These two pathways are complementary and maintain the activity of 
mitochondria. These authors show that, in a worm genetic model of UPRmt, RNAi-mediated silencing 
of eukaryotic translation initiation factor 2-Į kinase 4/GCN2-like protein (GCN2) is associated with the 
accumulation of carbonylated proteins and decreased oxygen consumption, despite enhanced activity of 
the mtHSP70-GFP reporter plasmid. Conversely, upon mitochondrial stress, the inhibition of the UPRmt 
increases the load on the ISR, as demonstrated by an increased eIF2Į phosphorylation. In addition, 
concomitant alterations of both pathways result in growth defects, even in the absence of any stress [75]. 
In addition, boosting the NAD+ level not only activates Sirtuins and, especially, mitochondrial  
Sirtuin 3 [76], but also induces mitonuclear protein imbalances and activates UPRmt [67]. Importantly, 
these authors revealed that, in mice and C. elegans, in time-course experiments, treatments with 
nicotinamide riboside (NR), a NAD+ precursor led to a protective response in a two-step process. First, 
during the early phase response (one day of treatment), the UPRmt was activated, with the associated 
increase in ClpP and HSP6 expression. Then, after three days of treatment with NAD+ booster/NR,  
with the UPRmt markers still overexpressed, an antioxidant response was also triggered, as demonstrated 
by enhanced activation of the promoter of the gene encoding SOD3 and nuclear localization of the 
transcription factor daf-16 (FOXO3A orthologue in mammals). Interestingly, it appears that both 
pathways might be interconnected; the induction of Extracellular superoxide dismutase [Cu/Zn] (SOD3) 
was dependent on UBL-5, a transcriptional regulator activated during the UPRmt [67]. 
1.2.2. The UPRmt Models in Mammals 
In mammals, two different models of UPRmt have been described (Figure 1). While Hoogenraad’s 
group described a DDIT3 (DNA damage-inducible transcript 3 protein)/CHOP-10-dependent UPRmt 
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induced by the overexpression of a truncated form of a mitochondrial matrix enzyme [77], Germain and 
colleagues reported a CHOP-10-independent UPRmt model in which protein aggregates accumulated 
within the internal membrane space (IMS) when a mutant (catalytically inactive enzyme) form of 
endonuclease G (N174A) was overexpressed in breast adenocarcinoma MCF-7 cells [78]. 
 
Figure 1. The UPRmt models in mammalians. Two major independent models of UPRmt have 
been described. When unfolded proteins accumulate in the mitochondrial matrix, they are 
first cleaved by ClpP proteases. Peptides exit mitochondria by unknown mechanisms and 
trigger a signaling pathway, leading to the activation of c-Jun N-terminal kinase (JNK)  
and PKR, which phosphorylate as c-Jun (part of AP-1 transcription factor) and eIF2Į, 
respectively. The phosphorylation of eIF2Į can also be mediated by GCN2 in response to 
mitochondrial translation inhibition (not illustrated), and it turns on the integrated stress 
response (see Figure 2). PKR could also activate JNK. The activation of c-Jun triggers 
CHOP-10 expression. In turn, the transcription factor regulates the expression of  
stress-resolving genes such as mitochondrial proteases and chaperones (left side of the chart). 
When unfolded proteins accumulate in the inter-membrane space, the UPRmt is mediated by 
the activation of ERĮ, triggered by an AKT-dependent phosphorylation. The activation of 
AKT would then be mediated by oxidative stress, as inhibited by N-acetylcysteine (NAC). 
Mitochondrial stress resolves by an increase in the expression of HTRA2/Omi protease and 
enhanced proteasome activity, while the biogenesis of mitochondria is enhanced and under 
the control of NRF1, a target gene of ERĮ. The highlighted acronyms represent genes for 
which an endogenous differential expression (RT-qPCR or Western blot analysis) in response 
to UPRmt has been experimentally demonstrated to be dependent on CHOP-10; this is in addition 
to analysis using reporter constructs. The non-highlighted genes refer to genes controlled by 
CHOP-10 in response to a UPRmt, but only demonstrated using reporter constructs. 
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Accumulation of Unfolded Proteins within the Mitochondrial Matrix 
Pioneering work by Hoogenraad and collaborators first showed the selective induction of mitochondrial 
chaperones HSPD1 and HSPE1 in response to complete mitochondrial genome depletion (ȡ°) in rat 
hepatoma H4 cells [60]. Later on, they set up a UPRmt model based on the overexpression of a truncated 
form of the mitochondrial ornithine carbamoyltransferase (OTC) enzyme (OTC¨). The truncated form 
of the enzyme, while correctly localized in the organelle matrix, formed aggregates associated with  
the insoluble fraction after detergent extraction [79]. First clues of a UPRmt have been described in  
the monkey kidney COS-7 cell line, as aggregated protein elimination correlates with the up-regulation 
of HSPD1 and ClpP. Therefore, OTC¨ abundance decreases when chaperones and proteases are 
overexpressed, yet abundance of the wild type OTC remains stable. In addition, co-immunoprecipitation 
experiments have also shown that HSPD1 and ClpP were bound to OTC¨ but not to its wild type 
counterpart [79]. 
Hoogenraad and colleagues also used reporter plasmids to highlight the induction of several genes 
that encoded mitochondrial proteins in response to OTC¨ aggregation such as chaperones (HSP60, 
HSP10, DnaJ homolog subfamily B member 1/HSP40, mitochondrial-processing peptidase subunit ȕ, 
mitochondrial thioredoxin/MTRX), proteases (ClpP, ATP-dependent zinc metalloprotease YME1L1), 
and other mitochondrial proteins (Tim17, NADH dehydrogenase (ubiquinone) 1ȕ subcomplex subunit 
2/NDUFB2, caspase recruitment domain-containing protein 12/CARD12, endonuclease G, cytochrome C 
reductase) [80]. However, it is important to emphasize that increased expression of most of these target 
genes using artificial reporters has not been confirmed for endogenous-related genes [81] (personal 
unpublished data)—an observation that could be explained by differential epigenetic regulation and 
chromatin remodeling between a naked DNA promoter in the reporter construct and the DNA of 
authentic endogenous promoters [81]. In addition, the response seems to be specific; no change has been 
detected in the abundance for the UPRer gene markers (BiP/GRP-78/78 kDa glucose-regulated protein, 
endoplasmin/GRP-94/94 kDa glucose-regulated protein), for cytosolic chaperones (Heat shock cognate 
71 kDa protein, heat shock-related 70 kDa protein 2), and the requirement for mitochondrial localization. 
Demonstrated as the induction of nuclear gene encoding, mitochondrial proteins were not observed when 
cells were transfected with OTC¨ lacking the mitochondrial signal peptide [77,79]. 
Since these works, few advances have been made in the comprehension of mechanisms by which  
a UPRmt is set up in mammals. However, the pathological relevance of the protein kinase RNA-activated 
(PKR) and the UPRmt emerged in two murine models of colitis as well as in patients with inflammatory 
bowel diseases (IBDs) [82]. The expression of PKR increases in Mode K intestinal epithelial cells that 
overexpress the truncated form of OTC (OTC¨). Silencing experiments pointed out that PKR might play 
a role in the early phase of the UPRmt; the silencing of the kinase expression using siRNA prevents  
the phosphorylation of c-Jun and the induction of CHOP-10 [82]. In addition, these authors showed  
a PKR-dependent phosphorylation of eIF2Į, suggesting the concomitant induction of ISR and UPRmt, 
as previously described in C. elegans [82]. Various strategies were used to disrupt the stoichiometric 
equilibrium between nuclear- and mitochondrial-encoded ETC (Electron Transport Chain) subunits to 
trigger a UPRmt. Among them, doxycycline, an inhibitor of mitochondrial translation, triggered the 
activation of a UPRmt activation in AML12 cells (a mouse hepatic cell line), as demonstrated by  
an increased expression of HSPD1 protein and the activation of a reporter gene driven by the ClpP 
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promoter [45]. Similar results were obtained when mitochondrial protein abundance was increased by 
either increasing the NAD+ concentration with two precursors of its synthesis (nicotinamide mononucleotide 
(NAM) and nicotinamide riboside (NR)) known to trigger the expression of several nuclear gene 
encoding mitochondrial proteins in an NAD-dependent protein deacetylase Sirtuin-1 (SIRT1)-dependent 
manner [83] or by boosting mitochondrial biogenesis by mTOR inhibition with rapamycin [67].  
In primary murine hepatocytes, it was also confirmed that an antioxidant response mediated by 
superoxide dismutase 2 (SOD2) was associated with the UPRmt, and that both responses were dependent 
on the Sirtuin-1 deacetylase [67]. Interestingly, at least one other Sirtuin is involved in the resolution of 
mitochondrial proteotoxic stress. Indeed, NAD-dependent protein deacetylase Sirtuin-3 (SIRT3) has 
been shown to be activated in response to a large panel of mitochondrial stresses known to induce the 
accumulation of protein aggregates and/or ROS, including antimycin A, rotenone, an inhibitor of heat 
shock protein HSP90 and the overexpression of mutated EndoG (ǻMLS-Endo G-His), mutated SOD1, 
and OTC¨. These mitochondrial stresses activated an antioxidant response and mitophagy in a  
SIRT3-dependent manner, but the possible SIRT3-dependency of the UPRmt (evaluated by CHOP-10 
and HSP60 mRNA levels) was not reported. Interestingly, the proteotoxic stress resulted in a 
heterogeneous mitochondrial phenotype, a fraction of the mitochondria under severe stress. The cell 
viability under proteotoxic stress was compromised in the absence of SIRT3. Altogether, this set of data 
suggests that cells undergoing proteotoxic stress present a heterogeneous adaptive response with the 
induction of a UPRmt to resolve the stress in mildly affected mitochondria and a SIRT3-orchestrated 
mitophagy to remove irreversibly damaged organelles [84]. 
Despite the requirement for HAF-1 to observe the activation of a UPRmt in C. elegans, no clear 
mammalian orthologue of this protein has been identified thus far. However, Rainbolt and colleagues 
confirmed that, in mammalian cells, the expression of the worm Tim17 mutant and the reduction of 
mitochondrial imported induce UPRmt. In addition, the knock down of Tim17 in HEK293 cells resulted 
in a slight increase in HSPD1 and YME1L1 mRNA abundance [74]. Interestingly, these authors proposed 
a stress pathway based on the phosphorylation of eIF2Į and the attenuation of translation that leads to  
a down-regulation of Tim17 abundance, which is further enhanced by an increased YME1L1-dependent 
degradation of the protein. Ultimately, a lower abundance of Tim17 and, as a consequence, the reduced 
mitochondrial protein import might thus facilitate the activation of the UPRmt [74]. 
As for HAF-1, no mammalian orthologue of ATFS-1 has been identified to date. Detailed mechanisms 
as well as several actors of the UPRmt are thus still likely missing in mammals, especially regarding  
the effectors involved in the transcriptional regulation of target genes. However, both DVE-1 and UBL5 
have mammalian orthologues: SATB2 and UBL5, respectively [68]. Interestingly, SATB2 is a global 
chromatin organizer, and this protein is also able to form a complex with UBL5; however, no evidence 
of involvement of SATB2/UBL5 in the mammalian UPRmt has been experimentally demonstrated  
thus far [68]. 
The analysis of the HSPD1/HSPE1 bidirectional promoter revealed the existence of a CHOP-10-C/EBPȕ 
binding element crucial for the activation of the UPRmt-responsive genes. In addition, the abundance of 
these two transcription factors increased upon the overexpression of OTC¨ [79,80]. As in C. elegans, 
the current mammalian model of the UPRmt-induced gene expression would be a two-step process.  
It would firstly require the expression of transcription factors, such as CHOP-10, which would in turn 
activate the expression of gene encoding of mitochondrial chaperones/chaperonins and proteases. 
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In terms of upstream signaling pathways, it seems that the phosphorylation of c-Jun by JNK2 and/or 
PKR is necessary to activate the expression of these transcription factors [77,82]. Phosphorylated  
c-Jun would bind to an AP-1 binding site within the CHOP-10 promoter, allowing the regulation of  
a UPRmt-specific gene expression. These genes do not contain the well-described endoplasmic reticulum 
stress response element (ERSE) required for the classic genes regulated during the UPRer [80]. However, 
considering the multiple cell responses involving CHOP-10 and the putative 3522 promoters of nuclear 
genes predicted to contain the binding consensus element for this transcription factor, it is likely that 
additional factors are required to specifically regulate gene expression during the UPRmt [80].  
The sequence alignment of the 1000 bp promoter sequences of the UPRmt-induced genes revealed  
two well-conserved elements (except for the HSPD1/HSPE1 bidirectional promoter) surrounding the 
CHOP-10 binding site at a constant distance, named MURE1/2 (Mitochondrial unfolded protein 
response element 1/2) [80]. The requirement of these regulatory elements was demonstrated by reporter 
plasmid experiments as mutations within MURE1 or MURE2 to reduce the transcriptional activity of 
the UPRmt-target genes triggered by the overexpression of OTC¨ [80]. However, the relevance of the 
MURE1-CHOP-10-MURE2 element might be questionable because (i) it has not been confirmed since 
then; (ii) this motif was widespread in the genome and was not restricted to the UPRmt responsive genes 
(personal unpublished data); and (iii) the ligands putatively associated with these two regulatory 
elements have not yet been identified. 
IMS-Associated mtUPR 
In addition to the UPRmt initiated by events occurring in the mitochondrial matrix, Germain and Papa 
described another UPRmt model triggered by mitochondrial IMS protein aggregate accumulations, which 
caused the overexpression of a mutant form of endonuclease G (EndoG-N174A) in breast cancer  
MCF-7 cells, a condition that increases HTRA2/OMI protein abundance (a mitochondria-located serine 
protease that can be released by mitochondria during apoptosis) [85], NRF1 expression, and enhanced 
proteasome activity [78]. To contrast with OTC¨-induced UPRmt, the IMS stress response is not 
dependent on CHOP-10 expression, but rather relies on the ligand-independent activation of estrogen 
receptor Į (ERĮ). It has been clearly shown that the overexpression of EndoG-N174A induces the  
RAC-Į serine/threonine-protein kinase/AKT/PKB-dependent phosphorylation of ERĮ phosphorylation 
(Ser167). Additionally, AKT activation is dependent on ROS production triggered by the IMS stress as 
a treatment, with the antioxidant N-acetyl cysteine (NAC), completely abolishing the activation of  
ERĮ [78]. More recently, this research group deciphered events associated with IMS stress in triple 
negative cancer cells (lacking ERĮ) and highlighted the involvement of the mitochondrial SIRT3 in the 
regulation of the antioxidant response and mitophagy [84]. Strikingly, while these authors had previously 
shown that EndoG-N174A overexpression in MCF-7 cells did not induce a cell signaling response 
comparable to the one observed in response to the accumulation of truncated OTC in the mitochondrial 
matrix, in ERĮ-deficient breast cancer cells, they recently revealed that IMS stress also increases the 
expression of CHOP-10 and HSPD1 [84]. 
In conclusion, it seems that different retrograde responses that are dependent on the mitochondrial 
compartment and location at the origin of the stress could be initiated. Indeed, as we have seen, different 
quality control factors have been described, depending on the organelle compartment, such as ClpP and 
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HSPD1, for matrix proteins or serine protease HTRA2/Omi and the proteasome for IMS proteins.  
Thus, because initiating stress and responding effectors to recover protein homeostasis are different 
between the matrix and IMS stress, this may explain the existence of independent signaling pathways 
such as those described with CHOP-10 and OTC¨, or ERĮ and EndoG-N174A. In a recent study, we 
showed that, the transcription factor CHOP-10 was systematically overexpressed when the expression 
of mtDNA was inhibited by different means and in different cell types, while the UPRmt-related gene 
markers HSPD1 and ClpP were not induced [86]. Furthermore, increased expression of this transcription 
factor correlated with the activation of another stress-responsive pathway called the integrated stress 
response (ISR) [86]. 
1.3. The Integrated Stress Response (ISR) 
Although the integrated stress response (ISR) is not usually described as a typical retrograde response, 
several studies reported its activation in response to mitochondrial dysfunction [86–90]. The next 
paragraph presents the main features of ISR as well as its crosstalk with mitochondrial stress because it 
is a complementary pathway to the UPRmt. 
 
Figure 2. Hypothetical model for stress response to mitochondrial dysfunction. In response 
to various stresses, several kinases, such as HRI, PKR, PERK, and GCN2, are activated and 
converge to phosphorylate the translation initiation factor eIF2Į. In turn, the phosphorylation 
of eIF2Į has at least two consequences. While the cytosolic translation is globally attenuated 
as it inhibits CAP-dependent translation, mRNAs containing a uORF are preferentially 
translated, such as the transcription factor ATF4, which controls the expression of CHOP-10. 
The profit of this GCN2-eIF2Į-ATF4 pathway might be stress attenuation gained by 
relieving the load of proteins imported into the mitochondria and increasing the expression 
of integrated stress responsive genes. 
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The ISR is a stress adaptive pathway conserved by evolution as recovered from yeast to human.  
In mammals, molecular effectors of this signaling pathway (Figure 2) are activated during ER stress, 
amino acid depletion [91], virus infection, oxidative stress, heme deprivation, or UV irradiation [92]. 
These stressors are sensed by four different kinases: Eukaryotic translation initiation factor 2-Į kinase 
1/heme-regulated inhibitor (HRI), PKR, RNA-dependent protein kinase-like endoplasmic reticulum 
kinase (PERK), and general control non-derepressible 2 (GCN2) that converge to the phosphorylation 
of eIF2Į eukaryotic translation Initiation Factor 2Į at serine 51 [93]. Phosphorylation of eIF2Į is  
a central event of the ISR; it integrates upstream signals to reduce the ATP-consuming events, such as 
cytosolic translation, and to regulate the specific expression of a set of nuclear genes. Phosphorylated 
eIF2Į (P-eIF2Į) inhibits recycling of its GTP-bound form (active) by eIF2B, which is required for 
delivery of the methionyl-tRNA to the ribosome during translation initiation [94]. In addition, P-eIF2Į 
also elicits preferential translation of mRNAs containing an upstream open reading frame (uORF) in 
their 5މ-leader sequence such as the bZIP transcription factor activating transcription factor (4ATF4). 
Under unstressed conditions, translation initiation occurs at the start codon of the first uORF (uORF1) 
within the 5މ-leader of ATF4 mRNA. While the ribosome scans the sequence, after translation termination 
at the uORF1, the ribosome does not dissociate from the mRNA and resumes scanning to reach uORF2. 
When eIF2Į is not phosphorylated, it is rapidly recycled in its eIF2Į-GTP form—a reaction that allows 
rapid re-initiation of translation at the site. However, the inhibitory uORF2 is out of frame from the 
ATF4 coding region, and the ribosome dissociates without translation of ATF4. When cells are  
under stressful conditions, the availability of eIF2Į-GTP decreases and after termination at uORF1,  
the ribosome will scan through uORF2 because there is not enough eIF2Į-GTP to re-initiate translation 
in a rapid manner. As the ribosome scans to reach the coding sequence of ATF4, eIF2Į-GTP is 
sufficiently recycled to initiate translation at the start codon [92]. 
ISR also regulates gene expression by an interconnected set of transcription factors, such as ATF3 
and CHOP-10, which are both induced by ATF4. Together with other bZIP transcription factors, they 
regulate many other downstream genes, such as homocysteine-responsive endoplasmic reticulum-resident 
ubiquitin-like domain member 1 (HERPUD1) and tribbles homolog 3 (TRIB3), which first help to either 
resolve the stress or, alternatively, to induce apoptosis if the stress is too severe or persists for too  
long [91]. The protein encoded by HERPUD1 is a protective protein that participates in the endoplasmic 
reticulum-associated degradation (ERAD) pathway during ER stress [95]. Interestingly, these authors 
showed that HERPUD1 might be neuroprotective during ER stress by stabilization of Ca2+ storage and 
maintenance of mitochondria function [95]. The tribbles homolog 3 protein is a pseudo-kinase because, 
despite having a region of high homology with kinase domains, it lacks a consensus sequence for protein 
phosphorylation. So far, TRIB3 is known to directly interact with different proteins, such as AKT, 
C/EBPs (CCAAT/enhancer binding proteins), and ATF4/CHOP-10, thereby regulating the biological 
process and responses such as insulin signaling, autophagy, adipogenesis, and induction of apoptosis, 
respectively [96]. 
The ISR is interconnected with several pathways, and some effectors are shared by other signaling 
such as the UPRer or the UPRmt [82]. In addition, the GCN2 kinase can be activated by amino acid 
depletion, glucose depletion, UV irradiation, proteasome inhibition, and oxidative stress [93].  
The mechanism of activation upon amino acid starvation is well described. Under normal conditions, 
the kinase is kept inactive by auto-inhibitory molecular interactions. Upon binding of unloaded tRNA to 
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the histidyl-tRNA synthetase-like domain, an allosteric rearrangement creates an open conformation  
of the protein, and GCN2 is activated by auto-phosphorylation (Thr898 and Thr903) within the  
activation loop [97]. 
This kinase is a good example to illustrate divergent signaling pathways of the cell responses 
following eIF2Į phosphorylation. Indeed, while the signaling pathway downstream the P-eIF2Į 
triggered by the UV-irradiation enhances the activation of NF-țB and cell survival, the phosphorylation 
of eIF2Į in response to the inhibition of proteasome leads to the expression of CHOP-10 [98,99].  
As mentioned, CHOP-10 is a pleiotropic transcription factor that can form heterodimers with other 
members of the bZIP family transcription factors, such as C/EBPs and ATF4, to function either as  
a trans-activator or a trans-repressor of target genes [100–102]. Moreover, while CHOP-10 has been 
associated with apoptosis in many different conditions, paradoxically, recent studies have revealed that 
it can also promote cell survival during ER stress and amino acid starvation by regulating the expression 
of several autophagy-related genes such as p62, ATG5, ATG7, and ATG10 [103,104]. The resulting 
pro- or anti-apoptotic response is most likely dependent on the integration and balance of multiple 
signals that are activated in parallel with the cell nuclear background, together with the type/origin, 
nature, severity, and duration of the stress. 
In addition to this coordinated expression of chaperones and proteases, when the defect is too severe, 
the next level of quality control is the degradation of the entire organelle by specific autophagy called 
mitophagy [105]. We have seen clearly that mitochondria display several lines of quality control 
mechanisms: mitochondria-specific chaperones and proteases protect against misfolded proteins at the 
molecular level, and fission/fusion and mitophagy segregate and eliminate damage at the organelle  
level [9]. Therefore, if an increase in unfolded proteins in mitochondria activates a UPRmt to increase 
chaperone production, the mitochondrial serine/threonine-protein kinase PINK1 and the E3  
ubiquitin-protein ligase parkin, whose mutations cause familial Parkinson’s disease, remove depolarized 
mitochondria through mitophagy [106]. This research group also showed that both phenomenon were 
linked; the expression of unfolded proteins in the matrix causes the accumulation of PINK1 on 
energetically healthy mitochondria, resulting in mitochondrial translocation of Parkin and mitophagy 
and subsequent reduction of unfolded protein load, a response that is strongly enhanced by the 
knockdown of the mitochondrial Lon protease homolog [105]. 
1.4. What Is the (Patho)Physiological Relevance of a UPRmt in Mammals? 
1.4.1. The UPRmt and Neurodegenerative Diseases 
The accumulation of unfolded or aggregated proteins is a hallmark of a number of neurodegenerative 
diseases, including Alzheimer’s disease (AD) and Parkinson’s disease (PD), although it is currently 
unclear if these protein aggregates participate or are the consequence of such pathologies. For instance, 
extracellular amyloid ȕ deposits are characteristic of AD, but they are also present in mitochondria [107]. 
Amyloid ȕ precursor protein is cleaved by the mitochondrial HTRA2/Omi serine protease [108] and the 
latter has been shown to delay the aggregation of the amyloid ȕ 1–42 peptide [109]. Although HTRA2 
is a target gene of IMS-induced UPRmt (Figure 1), a putative role of the UPRmt in this pathology has not 
been demonstrated clearly. Regarding PD, accumulation of Į-synuclein has been demonstrated in the 
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mitochondria of post-mortem brains of PD patients as well as in cell models of PD [110,111]. 
Interestingly, a higher level of misfolded respiratory proteins was detected in post-mortem brains of PD 
patients, which correlates with an elevated abundance of HSP60 [112], suggesting the occurrence of  
a UPRmt. However, the UPRmt is still poorly characterized in PD models, contrary to mitophagy, because 
PINK and/or Parkin deficiencies are strongly associated with PD [113]. Clearly, investigating the 
relationship between the UPRmt and neurodegenerative diseases would be of great interest. In addition, 
the development of new tools to better monitor the UPRmt in vivo in individual cells would be welcome, 
as the mitochondrial proteotoxic stress generates a heterogeneous phenotype associated with a UPRmt 
and/or mitophagy [84]. 
1.4.2. The UPRmt in Aging 
One of the pioneering studies reporting a link between aging and the UPRmt was the silencing of  
cco-1, a subunit of Cytochrome c oxidase, in neuronal tissue of C. elegans, which increases lifespan and 
induces a UPRmt not only in neurons, but also in the intestine [55], suggesting an inter-tissue signaling 
that results in a UPRmt activation. Since then, the UPRmt has been implicated in increased lifespan in 
worms, flies, and mice, highlighting the importance of maintaining mitochondrial proteostasis for 
longevity. This aspect will not be developed here; several reviews have been recently devoted to UPRmt 
and aging [56,62,114]. 
1.4.3. The UPRmt and Stem Cells 
Recently, Mohrin and co-workers highlighted a SIRT7-NRF1 regulatory axis in the UPRmt and linked 
the UPRmt to hematopoietic stem cells’ (HSC) quiescence and aging [115]. They first demonstrated that 
the NAD+-dependent deacetylase SIRT7 is induced in response to a UPRmt. SIRT7 directly binds to  
the transcription factor NRF1, specifically on the promoter of gene encoding mitochondrial ribosomal 
proteins and mitochondrial translation factors, to reduce, indirectly, their expression. SIRT7 induction 
thus contributes to attenuating the mitochondrial translation, thereby decreasing the proteotoxic stress 
imposed on the organelle. In addition, SIRT7 deficiency results in a constitutive UPRmt. Because stem 
cells undergo an oxidative metabolic shift when entering into differentiation, it is not surprising that 
SIRT7, by limiting mitochondria biogenesis and the UPRmt, contributes to HSCs’ quiescence and 
prevents differentiation. Furthermore, the activation of a UPRmt observed in aged HSCs has been linked 
to SIRT7 decreasing in these cells, contributing to their decline. Interestingly, reintroduction of SIRT7 
in aged HSCs reduces the UPRmt and improves their regenerative capacities. Altogether, these 
authors concluded that the UPRmt might be an aged-sensitive metabolic checkpoint to regulate HSCs’ 
renewal properties. 
1.4.4. The UPRmt in Innate Immunity 
Several bacterial pathogens target the mitochondria, disrupting essential functions, such as calcium 
and redox homeostasis, or mitochondrial morphology [116]. However, the impact of pathogens on 
the UPRmt is still poorly described, especially in mammals. In C. elegans, several bacteria strains,  
and particularly P. aeruginosa, activate a UPRmt, as shown by a specific chaperone induction in the 
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intestine [117]. Because the worm is more susceptible to P. aeruginosa exposure when ATFS-1 
expression is down-regulated, the UPRmt might be protective against bacterial infection. In addition,  
the knockdown of an mtDNA-encoded ATP synthase subunit not only activates the UPRmt, but also  
the expression of innate immune genes and makes the worm more resistant to P. aeruginosa exposure. 
Finally, these authors showed that human cells undergoing a UPRmt also induce the transcription of 
antimicrobial peptides (reviewed in [113]). In line with these observations, PKR-mediated UPRmt has 
been highlighted in two murine models of colitis, as well as in patients with inflammatory bowel diseases 
under inflammatory conditions [82]. The UPRmt might thus represent one of the mechanisms that senses 
bacterial pathogens in the intestinal mucosae and adapts the cell functions and immune response 
(reviewed in [118]). However, it is still currently unclear whether PKR-dependent induction of a UPRmt 
in colitis models is detrimental or beneficial due to controversial data found in the literature [82,119]. 
Importantly, the sensitivity to the UPRmt may vary according to different parameters, including  
tissue-specificity and stress intensity. This has been demonstrated by Dogan and co-workers, who 
studied a mouse model that lacked a protein directly involved in mitochondrial translation, such as the 
gene DARS2 encoding the mitochondrial aspartate-tRNA ligase, specifically in heart and skeletal 
muscle tissues [120]. While both tissues presented a comparable mitochondrial respiratory deficiency, 
the strategies developed to cope with this proteotoxic stress were different, depending on the tissue. 
DARS2-deficient hearts from 6-week-old mice presented a mitochondrial cardiopathy, with an increase 
in mitochondria biogenesis and activation of a UPRmt, accompanied by reduced autophagy markers. 
However, 3-week-old mice showed no sign of cardiopathy, suggesting that the mitochondrial stress 
imposed by the conditional loss of DARS2 had not reached a sufficient level to trigger these stress 
responses. Conversely, these stress responses were not observed in the skeletal muscles of 6-week-old 
mice despite a 60% to 80% decrease in the activity of respiratory chain complexes, presumably because 
a low turnover of mitochondrial transcripts was the preferred strategy to cope with mitochondrial stress 
in this tissue [120]. 
2. Conclusions 
2.1. The UPRmt versus ISR or Both in Response to a Mitochondrial Stress? 
While the number of papers reporting on the UPRmt is ever growing, it is interesting to note that this 
stress response is still poorly defined in terms of target genes and signaling pathways, especially in 
mammalians. This is probably reinforced by the fact that some researchers tend to designate UPRmt as 
any kind of retrograde response triggered by a mitochondrial stress, even if the stress has not been 
associated with the accumulation of unfolded protein aggregates. Although the pioneering work  
performed by the group of Hoogenraad [79] established a large list of target genes specifically induced 
by the UPRmt (and not by the UPRer), these interesting findings were mainly obtained with reporter 
assays. Only a few of these target genes were shown later to be induced at the endogenous level by one 
or several of the mitochondria stressing conditions listed in Figure 1. These endogenous UPRmt targets 
were CHOP-10 [79], HSP60 [78,79,82,115], ClpP [115], and YME1L1 [74], although the last three 
UPRmt markers were generally induced in a modest manner. However, it is interesting to point out that 
other types of mitochondrial stresses, such as the inhibition of mitochondrial translation or the depletion 
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of mtDNA [86], MELAS and NARP mtDNA point mutations [88], inhibition of the respiratory chain 
by rotenone and antimycin A [89], or loss of HTRA2 expression [90] do not induce HSP60 and ClpP 
expression, but rather activate the integrated stress response (ISR) characterized by an attenuation of the 
cytosolic translation achieved through the phosphorylation of eIF2Į and by the induction of another set 
of target genes including CHOP-10, TRIB3, and HERPUD1 [86]. Importantly, Rainbolt and co-workers 
revealed that arsenite, an ETC inhibitor, triggered the ISR, with a transient phosphorylation of  
eIF2Į, accompanied by the induction of HSP60 and Tim17 at the transcript level, but not at the protein 
level [74]. Tim17 protein abundance strongly decreased in response to arsenite due to both a decreased 
biogenesis and an increased YME1L1-dependent degradation, thereby reducing the mitochondrial 
protein import. Interestingly, depletion of Tim17 by RNA interference not only reduced mitochondrial 
import, but also modestly increased (1.5-fold) the transcript level of HSP60 and YME1L1 [74]. 
Altogether, this suggests a two-wave response to the arsenite-induced mitochondrial stress: the first 
wave activated the ISR, with a transient phosphorylation of eIF2Į that reduces Tim17 synthesis.  
The lower mitochondrial import capacity associated with reduced Tim17 abundance in turn induced 
the transcription of some UPRmt target genes. It is important to know whether cooperation between 
the ISR and the UPRmt activation could be generalized to other types of mitochondrial stresses, which 
still needs to be addressed, although Haller’s group has already shown that the UPRmt observed in 
human intestinal epithelial cells overexpressing OTC¨ is dependent on PKR-mediated ISR [82]. 
Researchers interested in mitochondria-induced stress responses should therefore be encouraged to 
monitor the kinetics—systematically—of both the UPRmt and the ISR markers, including the efficiency 
of the mitochondrial import capacity. 
It is important to emphasize the fact that, while the ISR and the UPRmt were first discriminated based 
on the source of mitochondrial stress generated (depletion of mtDNA versus accumulation of misfolded 
proteins) in experimental models, it is most likely that a certain level of overlap exists between these 
two signaling pathways, especially as several effectors are common to both cell responses. One can 
easily imagine that mtDNA depletion and mutations affecting ETC that are known to trigger ISR could 
also eventually lead to ROS-dependent oxidation of mitochondrial proteins and lipids, causing defects 
in folding or misassembling of mitochondrial protein complexes, initiating a UPRmt. 
2.2. Future Directions 
Important questions remain unanswered regarding the UPRmt, as well as mitochondria-induced  
ISR. First, while the link between a mitochondria proteotoxic stress and the cytosolic UPRmt cascade is 
relatively clear in C. elegans, it remains poorly understood in mammals. Does the mammalian  
UPRmt signaling depend on peptide efflux? If so, what are the peptide transporters and the primary 
cytosolic targets? 
Second, the attenuation of cap-dependent translation, achieved through phosphorylation of eIF2Į,  
is a shared and common feature between the UPRer, the UPRmt, and the ISR (Figures 1 and 2). These 
three pathways are powerful mechanisms for alleviating the proteotoxic stress imposed on organelles 
or cytosol. However, an intriguing feature is the kinetics of eIF2Į phosphorylation: while transient 
in the case of a UPRer, it is sustained (up to 30–48 h) in the case of a UPRmt triggered by ¨OTC 
overexpression [82], and in the case of ISR, it is induced by the inhibition of mitochondrial translation [86]. 
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In response to a UPRer, it is known that the induction of encoding the protein phosphatase 1 regulatory 
subunit 15A/Growth arrest and DNA damage-inducible protein (PPP1R15A/GADD34) contributes to 
dephosphorylation of the phosphorylated form of eIF2Į and thus resumes cap-dependent translation. 
One might wonder how cells deal with a reduced cap-dependent translation for as long as 2–3 days,  
a phenomenon accompanied by cell growth arrest in some cell types, but not all of them (Sébastien Michel, 
University of Namur, Belgium. Personal communication, 2014). During this period, several ISR-target 
genes are induced. Even if the presence of internal ribosome entry sites (IRES) has been described for 
at least some of them, one cannot exclude a specific regulation at the translation level on these  
ISR-responsive transcripts, following the mechanism of RNA regulon control [121]. In line with this 
hypothesis, a recent multi-layered “omics” dissection of mitochondrial activity in the liver proteome 
from 40 strains of the BXD mouse genetic reference population revealed that six members of the  
UPRmt pathway are coordinately regulated; this occurs more strongly at the protein level than at  
the transcript level [122]. 
Third, the specificity of CHOP-10-dependent cell responses needs to be investigated. Indeed, 
CHOP-10 is induced in response to number of cell stress conditions, such as nutrient deprivation, viral 
infection, hypoxia, or accumulation of protein aggregates in organelles such as the endoplasmic 
reticulum and mitochondria. This transcription factor is undoubtedly a key actor for coordinating the 
adequate cell response that ranges from apoptosis, the UPRer, and the UPRmt to the ISR. In addition, 
CHOP-10 was also shown to reduce the proliferation of intestinal cells in models of acute and chronic 
colitis [123]. However, the molecular determinants that confer the specificity of CHOP-10-dependent 
stress-response are still largely unclear and might involve specific post-transcriptional modifications of 
CHOP-10 as well as the activation of additional transcriptional regulators. 
Fourth, while inducing chaperones and proteases to restore proteostasis makes sense, the biological 
significance of some ISR target genes in the context of a mitochondrial proteotoxic stress remains 
undetermined. For instance, it has been shown that the induction of TRIB3 participates in a negative 
feedback loop to repress most of the ATF4-dependent ISR target genes [124]. However, the biological 
role of other ISR-induced genes, and particularly the induction of several aminoacyl-tRNA synthetases 
in response to mitochondrial stresses [88,124], still requires analysis. Briefly, in all eukaryotes, 
aminoacyl-tRNA synthetases are sequestrated in large multimeric complexes, where they ensure their 
primary role of tRNA aminoacylation. It has been shown that upon release from these complexes, they 
can carry out alternative functions. When yeasts are submitted to the diauxic transition from anaerobic 
glycolysis to oxidative respiration, two aminoacyl-tRNA synthetases, cERS and cMRS, dissociate from 
their cytosolic anchor complex, relocating to the mitochondria and the nucleus, respectively. While 
cERS stimulates mitochondrial translation, cMRS triggers the transcription of nuclear gene encoding of 
ATP synthase subunits, enabling synchronization of the expression of mitochondria-encoded and 
nuclear-encoded subunits of the complex V [125]. The fact that non-canonical functions have been 
recently highlighted for two tRNA synthetases in the yeast could pave the way for new researches needed 
in the future to fully understand signaling and effectors of the UPRmt in mammalians. 
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